Vanguard Group’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Buy |
|
|||||
|
2025
Q1 | $15.2M | Buy |
|
|||||
|
2024
Q4 | $22.6M | Sell |
|
|||||
|
2024
Q3 | $22.5M | Buy |
|
|||||
|
2024
Q2 | $22.1M | Buy |
|
|||||
|
2024
Q1 | $22.4M | Buy |
|
|||||
|
2023
Q4 | $24.8M | Buy |
|
|||||
|
2023
Q3 | $15.7M | Buy |
|
|||||
|
2023
Q2 | $22.8M | Buy |
|
|||||
|
2023
Q1 | $24.2M | Buy |
|
|||||
|
2022
Q4 | $26.5M | Buy |
|
|||||
|
2022
Q3 | $30.3M | Buy |
|
|||||
|
2022
Q2 | $16.1M | Buy |
|
|||||
|
2022
Q1 | $23M | Buy |
|
|||||
|
2021
Q4 | $32.2M | Buy |
|
|||||
|
2021
Q3 | $33.6M | Buy |
|